Year in review 2012: Critical Care--respiratory infections.
Over the last two decades, considerable progress has been made in the understanding of disease mechanisms and infection control strategies related to infections, particularly pneumonia, in critically ill patients. Patient-centered and preventative strategies assume paramount importance in this era of limited health-care resources, in which effective targeted therapy is required to achieve the best outcomes. Risk stratification using severity scores and inflammatory biomarkers is a promising strategy for identifying sick patients early during their hospital stay. The emergence of multidrug-resistant pathogens is becoming a major hurdle in intensive care units. Cooperation, education, and interaction between multiple disciplines in the intensive care unit are required to limit the spread of resistant pathogens and to improve care. In this review, we summarize findings from major publications over the last year in the field of respiratory infections in critically ill patients, putting an emphasis on a newer understanding of pathogenesis, use of biomarkers, and antibiotic stewardship and examining new treatment options and preventive strategies.
Girish B
GB
Nair
Michael S
MS
Niederman
D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000592:standards*; D015415:Biomarkers; D017714:Community-Acquired Infections / Q000188:drug therapy* / Q000382:microbiology; D003428:Cross Infection / Q000209:etiology / Q000382:microbiology / Q000517:prevention & control* / Q000628:therapy; D018432:Drug Resistance, Multiple / Q000187:drug effects*; D017052:Hospital Mortality; D006801:Humans; D017053:Infection Control / Q000379:methods; D007362:Intensive Care Units / Q000458:organization & administration / Q000592:standards* / Q000639:trends; D011014:Pneumonia / Q000209:etiology / Q000382:microbiology / Q000517:prevention & control / Q000628:therapy; D012141:Respiratory Tract Infections / Q000382:microbiology / Q000517:prevention & control / Q000628:therapy; D012720:Severity of Illness Index; D012122:Ventilators, Mechanical / Q000009:adverse effects / Q000382:microbiology
D000890:Anti-Infective Agents; D015415:Biomarkers